Back to search

Article

Targeted chelation therapy decreases NLRP3 expression by vascular cells and acts as senomorphic in Chronic Kidney Disorder induced Vascular Calcification

2025-04-26

Abstract excerpt

<h4>Background</h4> Chronically high levels of phosphate (P) in the serum caused by chronic kidney disease (CKD) induce osteogenic changes in the aortic Vascular Smooth Muscle Cells (VSMCs). Premature onset of cellular senescence is observed in these phenotypically transitioned cells, which plays a critical role in pathology of vascular calcification. We have previously shown that EDTA therapy can remove calcium...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2e411794-34e8-52bb-8d28-f0e0dd5eb153
DOI
10.1101/2025.04.23.650230
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted chelation therapy decreases NLRP3 expression by vascular cells and acts as senomorphic in Chronic Kidney Disorder induced Vascular CalcificationDOI 10.1101/2025.04.23.650230
Select a neighboring publication to make it the new centre.